FEMS Microbiology Letters · 1993 · 32 citations · 14 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMolecular VirologyVirologyAntigen RecognitionEpitope MappingViral EpidemiologyViral HepatitisAntibodiesAntibody Epitope MappingB-cell EpitopesFecal-oral TransmissionHepatitis E Virus InfectionHepatitis Virus TestingLinear EpitopesPeptide Epitopes
Hepatitis E virus (HEV) is the causative agent of non-A, non-B hepatitis which is transmitted by the fecal-oral route and occurs principally in the form of large epidemics and outbreaks in developing countries. Two overlapping synthetic peptides corresponding to overlapping DNA sequences of the ORF 3 of HEV genome were found to be immunoreactive with sera from patients involved in two epidemics of enterically transmitted non-A, non-B hepatitis. The results suggested the existence of two distinct epitopes. The four synthetic peptides representing these two epitopes from Burma and Mexico strains of hepatitis E virus, were used to investigate anti-HEV reactivities. HEV antibodies were detected in 84-88% of HEV-infected individuals according to the peptide used. The results suggest that a peptide-based ELISA can provide an accurate tool for the diagnosis of acute hepatitis type E.
14
Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome
Albert W. Tam, Matthew M. Smith, M. Guerra et al. · Virology · 1991 · 1.1K citations · Full text
Molecular cloning and sequencing of the mexico isolate of hepatitis E virus (HEV)
Chiao-Chain Huang, Dat Tien Nguyen, John Fernandez et al. · Virology · 1992 · 330 citations
George J. Dawson, Kurt H. Chau, Carlos M. Cabal et al. · Journal of Virological Methods · 1992 · 253 citations